精益管理在多重耐药菌感染防控中的效果分析

doi:10.3760/cma.j.cn441417-20241011-06022

国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (6): 993-996.DOI: 10.3760/cma.j.cn441417-20241011-06022

精益管理在多重耐药菌感染防控中的效果分析

钟艳云赵艳群龚波易文华

广东药科大学附属第一医院感染管理科，广州 510080

收稿日期:2024-10-11 出版日期:2025-03-15 发布日期:2025-03-17
通讯作者: 易文华，Email：1120585970@qq.com
基金资助:
国家卫生健康委医院管理研究所医疗质量循证管理持续改进研究项目（YLZLXZ22G036）

Effect of lean management in prevention and control of multidrug-resistant bacteria infections

Zhong Yanyun, Zhao Yanqun, Gong Bo, Yi Wenhua

Department of Hospital Infection Management, First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510080, China

Received:2024-10-11 Online:2025-03-15 Published:2025-03-17
Contact: Yi Wenhua, Email: 1120585970@qq.com
Supported by:
Research Project for Continuously Improving Evidence-based Management of Medical Treatment Quality of Hospital Management and Research Institute, National Health Commission (YLZLXZ22G036)

摘要/Abstract

摘要：

目的　评估精益管理在医院多重耐药菌感染防控中的效果。方法　选择2023年1月至6月在广东药科大学附属第一医院检出的451例多重耐药菌患者作为对照组，2023年7月至12月检出的387例多重耐药菌患者作为试验组。对照组男297例、女154例，年龄（73.93±16.95）岁，实施精益管理前（常规管理）；试验组男260例、女127例，年龄（71.35±16.22）岁，实施精益管理后。对比两组患者基本情况，实施精益管理前后多重耐药菌核心防控措施执行率及医院感染发病率的变化，并评估精益管理效果。统计学方法采用t检验、χ²检验。结果　试验组接触隔离执行率、手卫生依从率、无菌操作执行率、清洁消毒合格率及多重耐药菌核心防控措施执行率均高于对照组［96.90%（375/387）比80.93%（365/451）、80.80%（324/387）比60.58%（252/451）、82.95%（321/387）比61.86%（279/451）、82.43%（319/387）比65.63%（296/451）、82.43%（319/387）比54.17%（244/451）］，差异均有统计学意义（χ²=119.820、40.145、42.761、17.836、53.101，均P<0.05）。精益管理前，医生和护士防控知识知晓率分别为69.80%（245/351）、73.15%（436/596），工勤人员仅为50.25%（102/203）；精益管理后，总体知晓率提高至90.60%（1 002/1 106）（均P<0.05）。试验组多重耐药菌医院感染例次率为0.15%（33/21 619），低于对照组的0.29%（55/19 265），差异有统计学意义（χ²=8.717，P<0.05）。结论　精益管理模式对多重耐药菌的防控有效，可有效降低多重耐药菌医院感染的发生。

关键词:

多重耐药, 精益管理, 防控措施

Abstract:

Objective To evaluate the effect of lean management in the prevention and control of multidrug-resistant bacteria infections in hospitals. Methods　A total of 451 patients with multidrug-resista bacteria detected at First Affiliated Hospital of Guangdong Pharmaceutical University from January to June 2023 were selected as a control group, and 387 patients with multidrug-resistant bacteria detected from July to December 2023 were selected as an experimental group. There were 297 males and 154 females in the control group; they were (73.93±16.95) years old. There were 260 males and 127 females in the experimental group; they were (71.35±16.22) years old. The basic data were compared between the two groups. The implementation rates of core multidrug-resistant bacteria prevention and control measures and nosocomial infection rates were compared between before and after the implementation of lean management. The effect of lean management was assessed. t and χ² tests were used for the statistical analysis. Results　The execution rate of contact isolation, hand hygiene compliance rate, aseptic operation execution rate, qualified rate of cleaning and disinfection, and execution rate of core prevention and control measures in the experimental group were higher than those in the control group [96.90% (375/387) vs. 80.93% (365/451), 80.80% (324/387) vs. 60.58% (252/451), 82.95% (321/387) vs. 61.86% (279/451), 82.43% (319/387) vs. 65.63% (296/451), and 82.43% (319/387) vs. 54.17% (244/451)], with statistical differences (χ²=119.820, 40.145, 42.761, 17.836, and 53.101; all P<0.05). The awareness rates of multidrug-resistant bacteria prevention and control knowledge by doctors, nurses, and sanitation workers were 69.80% (245/351), 73.15% (436/596), and 50.25% (102/203) before the implementation of lean management; after the the implementation of lean management, the overall awareness rate was 90.60% (1 002/1 106) (all P<0.05). The incidence rate of multidrug-resistant bacteria nosocomial infections in the experimental group was lower than that in the control group [0.15% (33/21 619) vs. 0.29% (55/19 265)], with a statistical difference (χ²=8.717; P<0.05). Conclusion　The lean management mode is effective in the prevention and control of multidrug-resistant bacteria, and can reduce the occurrence of multidrug-resistant bacteria nosocomial infections.

Key words:

Multidrug-resistant, Lean management, Prevention and control measures

钟艳云赵艳群龚波易文华.

精益管理在多重耐药菌感染防控中的效果分析 [J]. 国际医药卫生导报, 2025, 31(6): 993-996.

Zhong Yanyun, Zhao Yanqun, Gong Bo, Yi Wenhua.

Effect of lean management in prevention and control of multidrug-resistant bacteria infections [J]. International Medicine and Health Guidance News, 2025, 31(6): 993-996.

参考文献

[1] 蔡栋昊,刘灿华,李晓君,等. 某中医院糖尿病足感染患者伤口病原菌分布及其耐药性分析[J]. 国际医药卫生导报,2023,29(8):1086-1089.DOI:10.3760/cma.j.issn. 1007-1245.2023.08.012.
[2] 吴文斌,杨海玲,朱家馨,等. 老年医院获得性肺炎患者临床特征及死亡危险因素分析[J]. 实用医学杂志,2020,36(24):3425-3429.DOI:10.3969/j.issn.1006-5725.2020.24.024.
[3] 陈尔英,张冬群,罗永香,等. 经T管瘘道行肝内外胆管取出残留结石并发症相关因素风险预警模型构建与验证[J]. 实用医学杂志,2023,39(15):1961-1965.DOI:10.3969/j.issn. 1006-5725.2023.15.018.
[4] 中华医学会呼吸病学分会感染学组. 中国铜绿假单胞菌下呼吸道感染诊治专家共识(2022年版)[J]. 中华结核和呼吸杂志,2022,45(8):739-752.DOI:10.3760/cma.j.cn112147- 20220407-00290.
[5] 杨启文,吴安华,胡必杰,等. 临床重要耐药菌感染传播防控策略专家共识[J]. 中国感染控制杂志,2021,20(1):1-14.DOI:10.12138/j.issn.1671-9638.20218124.
[6] 王丽敏,都淑萍,王志娟. ICU多重耐药菌感染浅析及护理防控研究进展[J]. 国际医药卫生导报,2022,28(23):3292-3295.DOI:10.3760/cma.j.issn.1007-1245. 2022.23.009.
[7] 翟理祥,陈沛军. 广东省中医院文化建设的实践与探索[J]. 中国医院管理,2018,38(8):72-73.
[8] 张敏,黄亚琴,宣姗姗,等. ECRS管理模式对多重耐药菌医院感染防控质量的影响[J]. 华西医学,2023,38(3):374-379.DOI:10.7507/1002-0179.202211103.
[9] 欧志强,朱庆伟,刘彩霞. 分级管理模式在多重耐药菌医院感染防控中的应用评价[J]. 中国实用医药,2020,15(26):170-171.DOI:10.14163/j.cnki.11-5547/r.2020.26.075.
[10] 薛艳梅,张方方. 分级管理精准防控模式在多重耐药菌医院感染防控中的应用及效果探讨[J]. 中国社区医师,2022,38(36):153-155.DOI:10.3969/j.issn.1007- 614x. 2022.36.051
[11] 沈含章,夏加伟,刘莉,等. 结核病患者多重耐药菌定植或感染预判模型的构建[J]. 实用医学杂志,2022,38(13):1589-1594.DOI:10.3969/j.issn.1006-5725.2022.13.004.
[12] 李春燕,高晓东,史庆丰,等. 多重耐药菌感染管理的综合干预及效果研究[J]. 检验医学与临床,2021,18(3):300-303,307.DOI:10.3969/j.issn.1672-9455.2021.03.004.
[13] 汪宁宁,王绍娟,金奎东,等. 6S精益化管理在医院文化建设中的运用[J]. 中国医院管理,2019,39(5):77-78.
[14] 陆巧葱,梁蒙娜,巫祖强,等. 精益理念下6S管理在医院质量文化建设中的应用——以佛山某医院为例[J]. 现代医院,2023,23(3):391-394.DOI:10.3969/j.issn.1671- 332X. 2023.03.019.
[15] 孙青,陈慧丽,蒋娜,等. 精益管理在神经内科多重耐药管理的应用效果[J]. 中国实用医药,2019,14(19):162-164.DOI:10.14163/j.cnki.11-5547/r.2019.19.087.
[16] 熊妙华,陈小平,丘文军,等. 精益管理在降低多重耐药菌院感率中的应用效果[J]. 中国医药指南,2021,19(13):4-7.DOI:10.15912/j.cnki.gocm.2021.13.003.
[17] 缪玉秀,高焕新,许蜜. 精益管理在多重耐药菌医院感染预防与控制中的应用研究[J]. 实用临床医药杂志,2017,21(19):207-209.DOI:10.7619/jcmp.201719076.
[18] 翟英,陈晓康,赵明. 多部门合作在多重耐药菌医院感染防控中的作用[J]. 公共卫生与预防医学,2022,33(2):93-96.DOI:10.3969/j.issn.1006-2483.2022.02.021.

精益管理在多重耐药菌感染防控中的效果分析

Effect of lean management in prevention and control of multidrug-resistant bacteria infections

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

编辑推荐

Metrics